Sigyn Therapeutics, Inc.
SIGY
$4.15
$0.153.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 55.55% | -32.15% | -19.26% | 43.47% | -36.93% |
| Total Depreciation and Amortization | -62.16% | 1,500.00% | -46.15% | -42.31% | -30.19% |
| Total Amortization of Deferred Charges | -81.45% | 35.93% | -27.49% | -84.83% | 51.60% |
| Total Other Non-Cash Items | -13.91% | 738.11% | 121.92% | 72.81% | -- |
| Change in Net Operating Assets | -69.18% | 56.90% | 85.56% | 544.33% | 2,670.29% |
| Cash from Operations | -126.90% | 55.00% | 44.39% | 58.12% | 71.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 141.33% | -25.56% | 662.00% | -68.62% | -83.59% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 83.47% | -32.10% | 578.67% | -70.70% | -82.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -188.47% | 170.98% | 106.96% | -93.28% | -167.17% |